Nelson Vergel Beyond Testosterone Podcast

Unraveling Testosterone Therapy: Myths, Risks, and the Future

Join us as we dive into the world of testosterone therapy with insights from Dr. Khera a leading voice in men's health. With over 100 published articles, Dr. Khera brings credibility and depth to this crucial discussion. This episode serves as "Testosterone 101," cutting through the noise to explore the real risks, benefits, and the latest guidelines.
We address common myths surrounding testosterone therapy, such as its links to blood clots, heart attacks, and prostate cancer. Dr. Kara's research provides a nuanced perspective, challenging outdated assumptions and offering a comprehensive view of hormonal health.
Explore the impact of testosterone on fertility and the natural contraceptive effects it can have. We discuss alternative options like clomiphene citrate and HCG for those wanting to boost testosterone while preserving fertility.
Discover the "four pillars of testosterone optimization"—diet, exercise, sleep, and stress reduction—and how they can naturally enhance testosterone levels. Dr. Khera emphasizes the importance of these lifestyle changes in creating a balanced hormonal environment.
Looking to the future, we delve into exciting possibilities like nanotechnology and stem cell research that could revolutionize testosterone therapy. Imagine a future where lifespan is extended and hormonal health is restored naturally.
As we wrap up, the key takeaway is the importance of personalized medicine. Every individual is different, and having a knowledgeable doctor is essential for tailored treatment. Stay informed, stay curious, and make empowered decisions about your health.

Neurotransmitters Involved in Erectile Function & Libido

This podcast episode provides an extensive discussion on the complex interplay of factors influencing male sexual function, particularly sex drive and erection quality, beyond just testosterone. It outlines the neurochemical symphony involving dopamine, serotonin, testosterone, oxytocin, and vasopressin, explaining their individual roles and interactions within the hypothalamic command center. Furthermore, the text identifies multifactorial influences on sexual dysfunction, such as obesity, diabetes, cardiovascular disease, sleep deprivation, and stress. Finally, it addresses clinical implications and treatment approaches, emphasizing lifestyle interventions, testosterone therapy considerations, and sleep optimization, underscoring that optimal sexual health is deeply interconnected with overall physical and mental well-being.

How Your Circadian Clock Affects Your Testosterone- Deep Dive

This Beyond Testosterone podcast episode comes from an academic review article from the Asian Journal of Andrology, published in September-October 2025. This article, titled "Regulation of testosterone synthesis by circadian clock genes and its research progress in male diseases," examines the relationship between circadian rhythms and testosterone production in males. It explores how circadian clock genes centrally and peripherally regulate testosterone synthesis and secretion, and how disruptions in these rhythms are linked to various male health issues, including late-onset hypogonadism, erectile dysfunction, male infertility, and prostate cancer. The authors also discuss potential therapeutic approaches, such as chronotherapy and non-pharmacological interventions, for these conditions based on circadian rhythmicity. The episode concludes by highlighting current limitations in research and suggesting future directions for investigation.

Everything You Need to Know About Testosterone Replacement Therapy

This episode summarizes the key information presented in the "Low Testosterone Causes and Treatments" lecture by Nelson Vergel from ExcelMale.com. It covers the definition of low testosterone, its health risks, diagnostic methods, and treatment options, emphasizing practical advice and addressing common misconceptions.
Understanding Low Testosterone: Causes, Diagnosis, and Treatment – Summary
What is Testosterone Deficiency?
Testosterone, the principal male sex hormone (androgen), is also found in women at much lower levels. It influences hair growth, liver protein synthesis, sexual and reproductive health, mood, muscle strength, bone density, and red blood cell production. The decline in testosterone typically starts at ages 30-40, gradually dropping about 1.2% per year.
Defining Low Testosterone & Health Risks
Normal male levels: 350–1,100ng/dL. For women: 10–50ng/dL.
Symptoms: Decreased libido and sexual function, fatigue, mood disturbances, muscle and bone loss, increased fat, concentration and memory problems.
Risks begin to emerge under 300–350ng/dL: Higher metabolic syndrome, erectile issues, mortality, anemia, diabetes/fractures/depression, and arterial problems.
Diagnosis: Thresholds & Testing
Definitions vary (European, Endocrine Society, insurers) but generally <300–350ng/dL is considered low.
Diagnosis: Two morning, fasting total and free testosterone tests. LH, FSH help distinguish primary (testicular) vs. secondary (pituitary/hypothalamic) hypogonadism.
Additional tests: PSA, lipid panel, CBC, estradiol, prolactin.
Physiology & Hormonal Interactions
Testosterone is produced via the hypothalamic-pituitary-testicular axis, starting from cholesterol. Most testosterone circulates bound to proteins (SHBG, albumin); only 2% is “free” and bioactive. Conversion products (DHT, estradiol) profoundly affect male health, especially bone, fat, and cognitive function.
Causes of Low Testosterone
Common causes include aging, obesity, diabetes, chronic illness (liver/kidney/COPD), sleep apnea, drugs (steroids, opiates), genetics, environmental toxins, and other hormonal deficiencies. Sleep quality, weight, and exercise are key modifiable factors.
Treatment Benefits
Normalizing testosterone may improve sexual interest, mood, cognitive function, cardiovascular health, muscle mass, inflammation, glucose control, and quality of life. Most benefits manifest within weeks to months.
Potential Risks and Contraindications
Risks: Acne, oily skin, decreased HDL cholesterol, increased red blood cells (hematocrit: may require blood donation), rare gynecomastia, male pattern baldness, sleep apnea, anxiety, water retention, reduced fertility.
Contraindications: Untreated sleep apnea, high baseline hematocrit (>50%), high PSA or prostate cancer, certain blood clotting disorders.
Treatment Options
Gels: Easy, stable but risk of skin transfer, variable absorption.
Injections: More consistent, cheaper; newer dosages and subcutaneous techniques minimize “peak and valley” side effects.
Pellets: Longer duration, minor procedure required.
Nasal, oral, patches: Less popular due to side effects or convenience.
Compounded medications: Custom options (especially for women), growing regulation.
Speaker’s Practical Advice
Monitor hematocrit closely.
Never “cycle” TRT.
Use simple injection techniques.
Protect fertility with HCG.
Question testosterone boosters and avoid untested supplements.
Stay informed on new medical information and guidelines.
Ancillary Therapies
TRT may be combined with thyroid meds, HCG, vitamin injections, ED drugs, and other agents to optimize results.

Demystifying Testosterone for Women

This episode addresses common misconceptions about testosterone, particularly regarding its role in women's health. She explains that testosterone is present in all bodies, not just male, and that administering testosterone to women is not illegal in the U.S., despite the lack of FDA-approved female-specific doses. Dr. Casperson clarifies that physiological female doses will not masculinize women and highlights that testosterone's benefits extend beyond libido, influencing mood, cognition, and energy. Finally, she debunks the idea that testosterone therapy negatively impacts fertility or is only for postmenopausal women, noting its linear decline with age starting in the twenties.

Ibogaine: Is it the Solution to Addiction Treatment?

This podcast episode discussed Ibogaine, a powerful psychedelic with significant potential for treating addiction, trauma, and various mental health and neurological conditions. The conversation highlights Ibogaine's historical use, its unique therapeutic mechanisms, and the current landscape of its clinical application and policy in Brazil and the United States. Key themes include Ibogaine's efficacy, the critical need for safe and professionally supervised administration, challenges related to cost and stigma, and the urgent call for systemic reforms to healthcare and drug policy to maximize its accessibility and impact. The overarching message emphasizes Ibogaine's potential for "human restoration" and its role as a "genuine emancipation medication" against the backdrop of current, often ineffective, treatment models. 

Results of the Largest Study on Declining Male Fertility and Hormonal Trends

This podcast episode talks about new research showing that men’s hormone levels—specifically testosterone and luteinizing hormone (LH)—have dropped a lot over the past 50 years. The study looked at data from over a million healthy men and found that this drop isn’t just because men are older or heavier today.
Previous studies already showed that sperm quality is getting worse, but this new research suggests that the problem starts higher up, in the brain areas that control hormone production. Scientists aren’t sure exactly why this is happening. They looked at things like environmental changes and shifts in the population but couldn’t find a clear explanation, so it’s probably caused by many things working together. In summary, healthy men today have much lower key hormone levels than men did decades ago, and researchers are still trying to figure out why.

FDA Expert Panel on Menopause and HRT Recommends Removing Black Box Labels

This episode presents an overview of an FDA hearing on menopause, prompted by a campaign addressing the "black box" warning on vaginal estrogen products. This warning, despite evidence suggesting its safety and localized effect, has deterred both doctors and patients from utilizing it, leading to significant health issues like recurrent UTIs. The discussion also challenged the lingering misinformation from the 2002 Women's Health Initiative study, which incorrectly linked hormone therapy to severe risks based on a study of an older demographic. Furthermore, the hearing highlighted the lack of FDA-approved testosterone for women, forcing off-label prescriptions, and underscored the importance of comprehensive education for healthcare providers and patients on menopause management. The speaker also noted the absence of discussion on progesterone and emphasized the need for a collaborative healthcare ecosystem involving researchers, regulatory bodies, payers, clinicians, and patients to improve women's health outcomes.